首页> 外国专利> METHODS FOR PREDICTING OR DETERMINING ARTERIAL STIFFNESS USING PLASMA METABOLITES

METHODS FOR PREDICTING OR DETERMINING ARTERIAL STIFFNESS USING PLASMA METABOLITES

机译:血浆代谢物预测或测定动脉僵硬度的方法

摘要

The present invention relates to a method for providing information, which is necessary for diagnosing or prognosing cardiovascular complication, and a kit for diagnosing the cardiovascular complication. The method comprises the following steps of: (a) obtaining a sample including blood separated from a subject; and (b) measuring the concentration of plasma metabolites selected from a group consisting of L-leucine, palmitic amid, L-octanoylcarnitine, decanoylcarnitine, lactosylceramide, phosphatidicolin (18:2/18:2), and lyso-phosphatidicolin (18:2). According to the present invention, concentration of the plasma metabolites selected from the group consisting of L-leucine, palmitic amid, L-octanoylcarnitine, decanoylcarnitine, lactosylceramide, phosphatidicolin (18:2/18:2) in plasma of an overweight subject has correlation with the amount of the blood vessel stiffness. Lyso-phosphatidicolin (18:2) has a negative correlation with the blood vessel stiffness. The danger of the cardiovascular complication is high since the blood vessel stiffness is high when the concentration of plasma metabolites having the positive correlation is high or the concentration of plasma metabolites having the negative correlation is low. Therefore, the method of the present invention has an effect capable of usefully diagnosing the cardiovascular complication by analyzing the concentration of diverse plasma in the overweight subject and a value of a parameter and by determining the blood vessel stiffness.
机译:本发明涉及用于提供诊断或预后心血管并发症所需的信息的方法,以及用于诊断心血管并发症的试剂盒。该方法包括以下步骤:(a)获得包括与受试者分离的血液的样品; (b)测量选自L-亮氨酸,棕榈酰胺,L-辛酰基肉碱,癸酰基肉碱,乳糖基神经酰胺,磷脂酰胆碱(18:2/18:2)和溶血磷脂酰胆碱(18:2)的血浆代谢物的浓度)。根据本发明,超重受试者血浆中选自L-亮氨酸,棕榈酰胺,L-辛酰基肉碱,癸酰基肉碱,乳糖基神经酰胺,磷脂酰胆碱(18:2/18:2)的血浆代谢物的浓度具有相关性。与血管僵硬程度有关。溶血磷脂酰肌醇(18:2)与血管硬度呈负相关。当具有正相关的血浆代谢物的浓度高或具有负相关的血浆代谢物的浓度低时,由于血管僵硬性高,因此心血管并发症的危险性高。因此,本发明的方法具有能够通过分析超重受试者中的各种血浆的浓度和参数值并通过确定血管硬度来有效诊断心血管并发症的效果。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号